IL158828A0 - Novel heteroaryl derivatives, their preparation and use - Google Patents

Novel heteroaryl derivatives, their preparation and use

Info

Publication number
IL158828A0
IL158828A0 IL15882802A IL15882802A IL158828A0 IL 158828 A0 IL158828 A0 IL 158828A0 IL 15882802 A IL15882802 A IL 15882802A IL 15882802 A IL15882802 A IL 15882802A IL 158828 A0 IL158828 A0 IL 158828A0
Authority
IL
Israel
Prior art keywords
preparation
heteroaryl derivatives
novel heteroaryl
disorders
disorder
Prior art date
Application number
IL15882802A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of IL158828A0 publication Critical patent/IL158828A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15882802A 2001-06-29 2002-06-27 Novel heteroaryl derivatives, their preparation and use IL158828A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101036 2001-06-29
PCT/DK2002/000435 WO2003002556A1 (en) 2001-06-29 2002-06-27 Novel heteroaryl derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
IL158828A0 true IL158828A0 (en) 2004-05-12

Family

ID=8160598

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15882802A IL158828A0 (en) 2001-06-29 2002-06-27 Novel heteroaryl derivatives, their preparation and use

Country Status (27)

Country Link
US (2) US20040248883A1 (xx)
EP (1) EP1399438B1 (xx)
JP (1) JP2004535449A (xx)
KR (1) KR20040019026A (xx)
CN (1) CN1310909C (xx)
AT (1) ATE312094T1 (xx)
AU (1) AU2002344949B2 (xx)
BG (1) BG108531A (xx)
BR (1) BR0210401A (xx)
CA (1) CA2451228A1 (xx)
CZ (1) CZ2004156A3 (xx)
DE (1) DE60207857T2 (xx)
DK (1) DK1399438T3 (xx)
EA (1) EA006203B1 (xx)
ES (1) ES2252471T3 (xx)
HK (1) HK1068622A1 (xx)
HU (1) HUP0400344A2 (xx)
IL (1) IL158828A0 (xx)
IS (1) IS2425B (xx)
MX (1) MXPA03011769A (xx)
NO (1) NO326514B1 (xx)
NZ (1) NZ529460A (xx)
PL (1) PL365249A1 (xx)
SI (1) SI1399438T1 (xx)
SK (1) SK652004A3 (xx)
UA (1) UA75407C2 (xx)
WO (1) WO2003002556A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ529461A (en) * 2001-06-29 2005-09-30 H Novel indole derivatives
DE60231507D1 (de) 2001-07-20 2010-07-01 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
JP4741487B2 (ja) * 2003-07-02 2011-08-03 コーラス ファーマ，インコーポレイティド アズトレオナムｌ−リジン及びそれを調製するための方法
US7160888B2 (en) 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
JP2008521771A (ja) 2004-11-26 2008-06-26 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 改良された抗精神病活性および抗不安症活性を有するイソキサゾリン−インドール誘導体
CN102822167A (zh) 2010-01-04 2012-12-12 埃南蒂亚有限公司 用于制备利伐沙班的方法及其中间体
CN104672364A (zh) 2010-04-12 2015-06-03 湖南石油化学株式会社 使用包含噻吩稠合的环戊二烯基配体的过渡金属化合物制备烯烃-二烯共聚物的方法
KR101384412B1 (ko) 2010-04-12 2014-04-25 롯데케미칼 주식회사 티오펜-축합고리 사이클로펜타디에닐 리간드를 포함하는 전이금속 화합물을 사용한 폴리프로필렌의 제조방법
KR100986301B1 (ko) 2010-04-12 2010-10-07 아주대학교산학협력단 테트라하이드로퀴놀린 유도체로부터 유래한 티오펜-축합고리 싸이클로펜타디에닐 4족 금속 화합물 및 이를 이용한 올레핀 중합
ES2596717T3 (es) 2010-04-12 2017-01-11 Lotte Chemical Corporation Composición de catalizador para la polimerización de olefina y procedimiento de preparación de poliolefina usando la misma
JP5567209B2 (ja) 2010-04-12 2014-08-06 ロッテ ケミカル コーポレーション オレフィン重合用担持触媒およびこれを用いたポリオレフィンの製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2667068B1 (fr) * 1990-09-26 1994-09-09 Adir Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
NZ529461A (en) 2001-06-29 2005-09-30 H Novel indole derivatives

Also Published As

Publication number Publication date
ATE312094T1 (de) 2005-12-15
PL365249A1 (en) 2004-12-27
US20080027071A1 (en) 2008-01-31
UA75407C2 (en) 2006-04-17
EA200400102A1 (ru) 2004-04-29
HK1068622A1 (en) 2005-04-29
DK1399438T3 (da) 2006-04-18
CA2451228A1 (en) 2003-01-09
IS2425B (is) 2008-10-15
WO2003002556A1 (en) 2003-01-09
BG108531A (bg) 2004-08-31
DE60207857D1 (de) 2006-01-12
US20040248883A1 (en) 2004-12-09
SK652004A3 (en) 2004-09-08
NZ529460A (en) 2005-09-30
AU2002344949B2 (en) 2007-05-24
NO326514B1 (no) 2008-12-22
EP1399438A1 (en) 2004-03-24
CN1310909C (zh) 2007-04-18
HUP0400344A2 (hu) 2004-09-28
DE60207857T2 (de) 2006-07-20
SI1399438T1 (sl) 2006-04-30
BR0210401A (pt) 2004-08-17
NO20035673L (no) 2003-12-18
EP1399438B1 (en) 2005-12-07
US7393845B2 (en) 2008-07-01
NO20035673D0 (no) 2003-12-18
JP2004535449A (ja) 2004-11-25
KR20040019026A (ko) 2004-03-04
EA006203B1 (ru) 2005-10-27
IS7021A (is) 2003-11-10
MXPA03011769A (es) 2004-04-02
CZ2004156A3 (cs) 2004-05-12
CN1520410A (zh) 2004-08-11
ES2252471T3 (es) 2006-05-16

Similar Documents

Publication Publication Date Title
HK1068622A1 (en) Novel heteroaryl derivatives, their preparation and use
RS20120158A3 (xx) Fenil-piperazin derivati kao inhibitori resorbcije serotonina
WO2002064594A3 (en) 6-substituted pyrido-pyrimidines
IL248993B (en) erbb inhibitors
YU63202A (sh) Derivati 2-okso-1-pirolidina, postupci za njihovo dobijanje i njihove upotrebe
MXPA04005456A (es) Derivados de acetileno que tienen actividad antagonistica de mglur5.
MXPA03010232A (es) Compuestos de arilsulfonamida, para el tratamiento de la obesidad, de la diabetes tipo ii y de trastornos del sistema nervioso central.
WO2002085896A8 (en) Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
DE60213576D1 (de) ANTIDEPRESSIVE AZAHETEROCYCLYLMETHYL-DERIVATE VON 2,3-DIHYDRO-1,4-DIOXINOi2,3-föCHINOXALIN
MXPA03011766A (es) Novedosos derivados de indol.
MXPA05010678A (es) Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de recaptacion de serotonina.
MXPA04005151A (es) Compuestos terapeuticos.
DE60204882D1 (de) Zykloalkenylsulfonamidderivate
MXPA04001855A (es) Derivados de sistemas de indan-1-ol c2-sustituidos, metodos para la produccion de los mismos y su uso como medicamentos.
CO5150221A1 (es) Nuevas 3-fenoxi- y 3-fenilalquiloxi-2-fenil-propilaminas sustituidas
WO2003005969A3 (en) Tetrahydropurinones as corticotropin releasing factor
UA85198C2 (ru) Производные морфолина как ингибиторы повторного поглощения норэпинефрина
RS88803A (xx) Nova jedinjenja arilsulfonamida za lečenje gojaznosti, dijabetesa tipa ii i poremećaja cns